In an article published in Law.com, As FDA Lays Off Thousands, State AGs Step In to Probe Counterfeit Weight Loss Drugs, Keturah Taylor (State AG Group, Washington, D.C.) predicts enforcement will broaden beyond counterfeit GLP-1 drug manufacturers  to sweep in legitimate market participants. She emphasizes the need for these companies to engage early with state AGs to educate them and demonstrate regulatory compliance.

Read more here.